Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2025-12-24 @ 3:28 PM
NCT ID:
NCT05854992
Eligibility Criteria:
Treatments of Migraine With Triptans in Individuals With Elevated Cardiovascular Risk:
Inclusion:
* Aged \>=18 years
* At least 1 year history of migraine with or without aura
* Confirmed cardiovascular or cerebrovascular disease, including myocardial infarction (MI), coronary artery disease (CAD), cerebrovascular disease, stroke; or at least 2 cardiovascular risk factors, including diabetes, hyperlipidemia, hypertension, obstructive sleep apnea, peripheral vascular disease;
* At least 1 year of prior triptan treatment or no previous triptan treatment.
Exclusion:
• Prescription of ergot alkaloids or dihydroergotamine within 60 days before or after starting treatment
Treatments of Migraine With Triptans in Pregnant Women
Inclusion:
* Aged \>=18 years
* Pregnant woman
* Diagnosis of episodic or chronic migraine with or without aura before pregnancy
Exclusion:
• Prescription of ergot alkaloids or dihydroergotamine \<= 60 days before pregnancy or during pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05854992
Study Brief:
Protocol Section:
NCT05854992